Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
26-29 March, 2025
Not Confirmed
Not Confirmed
27-29 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
26-29 March, 2025
Industry Trade Show
Not Confirmed
27-29 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
10 Oct 2024
// BUSINESSWIRE
01 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/myrtelle-announces-significant-reduction-in-n-acetylaspartate-naa-a-key-biomarker-in-patients-treated-in-its-phase-12-clinical-trial-of-the-investigational-gene-therapy-raav-olig001-aspa-for-canavan-disease-302263264.html
06 Jun 2024
// Jenna Philpott PHARMACEUTICAL TECHNOLOGY
https://www.pharmaceutical-technology.com/news/moderna-and-myrtelle-among-those-picked-for-fda-rare-disease-programme/
05 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/myrtelle-announces-that-the-fda-has-selected-raav-olig001-aspa-gene-therapy-candidate-for-the-treatment-of-canavan-disease-for-the-support-for-clinical-trials-advancing-rare-disease-therapeutics-start-pilot-program-302164098.html
10 Oct 2023
// BUSINESSWIRE
31 May 2023
// BUSINESSWIRE
ABOUT THIS PAGE